The Global Allergy diagnostic and treatment market is anticipated to grow at a CAGR of 5.50% between 2018 and 2026. Allergies are abnormal responses by the immune system to specific allergens (e.g., foods, pollen mould, and animal dander). The Allergy diagnostic and treatment market is primarily driven by the following factors:

• High incidences and large economic burden of allergic diseases
• Rising environmental pollution
• Growing use of tobacco
• Presence of high unmet medical needs

To learn more about this report, request a free sample copy

The important drivers increasing growth in the Global Allergy diagnostic and treatment market is the high incidence and large economic burden of allergic diseases, coupled with the rising environmental pollution. The growth in industrialization causes an increase in pollution of air as well as a rise in a variety of air pollutants. Due to this, the allergic diseases are a more challenging field and more diverted. The common allergies observed in the world are Allergic Rhinitis, Drug Allergy, Food Allergy, Insect Allergy, Skin allergy, General Allergy, etc.

Treatments, Diagnostics, and Immunotherapy are the major segments based on which this market is segmented. The treatment market by availability comprises of Prescription and Over the Counter. The Prescription involves Symptomatic treatments to treat different stages of the allergic symptoms. The treatment market by administration comprises of Oral, Spray, Ocular, and Topical. The Oral administrations are widely used and are anticipated to grow significantly. Oral immunotherapy, also acknowledged as oral desensitization, is a way of persuading the body’s immune system to bear food that causes an allergic reaction. Alocril is an ocular drug that stabilizes and prevents actions from eosinophils and neutrophils and prevents neuronal actions. The Diagnostic segment comprises of Skin Testing and Antibody. The most prevalent type of allergy testing remains skin prick tests. For the sublingual immunotherapy approach, an allergist must confirm a patient’s sensitivity to an allergen through traditional allergy testing.

Adverse effects of drugs and lack of awareness about allergic diseases are the major factors hindering the Allergy diagnostic and treatment market. The difference between allergy and intolerance is unknown to the normal people. Also, there is a lack of awareness amongst the people about allergies. Certain allergic drugs can have adverse effects, ex: drugs for allergic rhinitis can cause harm to the nasal passages, nose bleeds, nasal irritation, watery eyes, itchy nose and throat, insomnia, and dizziness.

The Global Allergy diagnostic and treatment market segments include Treatments, Diagnostics, and Immunotherapy. They are further segmented as follows:-

• Treatments
  • Treatment market by the availability
  • Prescription
  • Over the counter
  • Treatment market by the administration
  • Oral
  • Spray
  • Ocular
  • Topical
  • Treatment market by-products
  • Antihistamines
  • Sympathomimetic, decongestants and combinations
  • Corticosteroids
  • Leukotriene
  • Mast cell stabilizers
• Diagnostics
  • Skin testing
  • Antibody
• Immunotherapy
  • Subcutaneous administration
  • Sublingual liquid solutions
  • Sublingual tablets

This report covers the present market conditions and the growth prospects of the Global Allergy diagnostic and treatment market for 2018-2026 and considered the revenue generated through the sales of Allergy diagnostic and treatments for Treatment, Diagnostics, and Immunotherapy to calculate the market size by considering 2017 as the base year.

Geographically, the Global Allergy diagnostic and treatments market has been segmented into four major regions, which include:

• North America: The U.S. & Canada
• Asia-Pacific: China, India, Japan, Australia & New Zealand & Rest of APAC
• Europe: The United Kingdom, France, Germany, Russia & Rest of Europe
• Rest of World: Latin America & Middle East and Africa

The Allergy diagnostic and treatment market in North America is expected to hold the largest share by 2026 owing to the growing competition from generics in the oral antihistamines and intranasal corticosteroid segments. However, there are also opportunities for the expansion of the immunotherapy segment in emerging markets. Allergies are the 6th leading cause of chronic illness. In the U.S, Allergic conditions are the most common health issues affecting children. On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the Allergic diagnostic and treatment . The market in APAC is expected to grow rapidly due to the increased healthcare spending in this region. Also, major growth opportunities may be created in countries such as China, Japan, and India because of the healthcare investments by the government of these respective countries and increased out-of-pocket expenditure by residing population.

The major market players of the global Allergy diagnostic and treatment market are:

• Allergan Plc
• Beckman Coulter
• Hitachi Chemical Diagnostics Inc.
• Johnson & Johnson
• Pfizer

Company Profiles covers analysis of important players.

Allergan PLC is a global pharmaceutical company established on 18^th Feb 2015, by Allen Chao and David Hsia. It is headquarters in Dublin, Ireland. In June 2015, it was acquired by Actavis, PLC.  Pfizer is another of the world’s largest research-based biomedical and pharmaceutical company, with its corporate headquarters situated in New York City and research headquarter in Groton, Connecticut. The company always tries to deliver innovative therapies that extend and significantly improve lives.

Key Findings of the Global Allergy Diagnostic and Treatment market:

• Allergic conjunctivitis is becoming increasingly prevalent
• Skin prick test is the most prevalent type of allergy testing
• Antihistamines treatment holds the largest market share